Functional differences of short and long isoforms of spastin harboring missense mutation.

Dis Model Mech

Structure and Activity of Normal and Pathological Biomolecules, INSERM U1204, Université Paris Saclay, Université d'Evry, 91000 Evry, France

Published: September 2018


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Mutations of the () gene encoding for spastin protein are the main causes of hereditary spastic paraplegia. Spastin binds to microtubules and severs them through the enzymatic activity of its AAA domain. Several missense mutations located in this domain lead to stable, nonsevering spastins that decorate a subset of microtubules, suggesting a possible negative gain-of-function mechanism for these mutants. Of the two main isoforms of spastin, only mutations of the long isoform, M1, are supposed to be involved in the onset of the pathology, leaving the role of the ubiquitously expressed shorter one, M87, not fully investigated and understood. Here, we show that two isoforms of spastin harboring the same missense mutation bind and bundle different subsets of microtubules in HeLa cells, and likely stabilize them by increasing the level of acetylated tubulin. However, only mutated M1 has the ability to interact with wild-type M1, and decorates a subset of perinuclear microtubules associated with the endoplasmic reticulum that display higher resistance to microtubule depolymerization and increased intracellular ionic strength, compared with those decorated by mutated M87. We further show that only mutated M1 decorates microtubules of proximal axons and dendrites, and strongly impairs axonal transport in cortical neurons through a mechanism likely independent of the microtubule-severing activity of this protein.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177001PMC
http://dx.doi.org/10.1242/dmm.033704DOI Listing

Publication Analysis

Top Keywords

isoforms spastin
12
spastin harboring
8
harboring missense
8
missense mutation
8
spastin
5
microtubules
5
functional differences
4
differences short
4
short long
4
long isoforms
4

Similar Publications

Spastic Paraplegia 4 (SPG4) is the most prevalent form of Hereditary Spastic Paraplegia (HSP), a neurodegenerative disorder characterized by progressive lower limb spasticity and debilitating gait impairment, primarily driven by axonal degeneration of corticospinal motor neurons (CSMNs). Caused by mutations in the gene encoding spastin, an AAA-ATPase involved in microtubule severing and intracellular organelle function, SPG4 accounts for 40-50% of autosomal dominant HSP cases, yet without effective treatments. Although reduced microtubule acetylation has emerged as a key pathological mechanism, whether and how distinct mutations lead to microtubule deacetylation and subsequent neurodegeneration remains unclear.

View Article and Find Full Text PDF

Neurite outgrowth is critically controlled by calcium influx-mediated cytoskeleton dynamics. Spastin, a AAA ATPase microtubule-severing protein, also plays an important role in neurite outgrowth. However, the detailed mechanisms underlying posttranscriptional fine-tuning spastin activity, particularly in the context of calcium signaling, remain elusive.

View Article and Find Full Text PDF

Several dozen mutations in the M87 isoform of the spastin enzyme have been associated with mobility impairment in hereditary spastic paraplegias. Some of them impact the structural determinants of two functional conformations of the protein: spiral and ring. Here we investigate the possible patterns between these disease-related residues in spastin and aligned regions in the closely related protein katanin toward their role in the transition of the two conformations, which is essential for both enzymes' function.

View Article and Find Full Text PDF
Article Synopsis
  • Spastic Paraplegia 4 (SPG4) is a serious neurological disorder that causes increasing weakness and stiffness in the legs, affecting walking ability, and is linked to mutations in the SPAST gene which encodes the spastin protein.
  • The review examines the two main forms of spastin (M1 and M87), their genetic structure, and their uncertain roles in SPG4, highlighting the need for more research on how these isoforms contribute to the disease's progression.
  • The authors propose new theories on how M1- and M87-spastin interact, suggesting this could lead to new treatment approaches for SPG4 and emphasizing the importance of understanding the specific functions of each spastin
View Article and Find Full Text PDF